Document Detail


Philosophy of antiarrhythmic approaches to ventricular tachyarrhythmias close to the 21st century.
MedLine Citation:
PMID:  9973859     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The scientific basis and the reasoning underlying the changes in antiarrhythmic approaches to ventricular arrhythmias during recent decades are discussed. The early enthusiasm in the use of antiarrhythmic drugs in patients after myocardial infarction to prevent sudden cardiac death was severely affected by the results of the Cardiac Arrhythmia Suppression Trial (CAST) which show an increased mortality of patients on sodium-channel antagonist antiarrhythmic drugs. A transient euphoria for drugs that prolong repolarization received criticism after premature termination of the Survival With Oral D-sotalol-trial (SWORD). Recently, attention has focused on the use of the implantable cardioverter defibrillator in both secondary and primary prevention of sudden death. In contrast, catheter ablation, although very useful in supraventricular tachycardia, still plays a limited role in the management of ventricular tachyarrhythmias in the presence of organic heart disease.
Authors:
G Breithardt; W Haverkamp; D Böcker; M Borggrefe
Related Documents :
2105049 - The cardiac arrhythmia suppression trial: background, interim results and implications.
6638049 - Sudden death during ambulatory monitoring. analysis of six cases.
7627789 - Ventricular dysrhythmias in ischemic heart disease.
1374889 - Sudden death in patients with congestive heart failure: future directions.
23264549 - Heart failure associated with adult congenital heart disease.
17208319 - Sudden death prophylaxis in heart failure.
9236569 - Patent foramen ovale in patients with cerebral infarction. a transesophageal echocardio...
12605969 - Myocardial perfusion changes in patients irradiated for left-sided breast cancer and co...
9127399 - Effects of an angiotensin ii antagonist on reperfusion arrhythmias in dogs.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Revista portuguesa de cardiologia : orgão oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology     Volume:  17     ISSN:  0870-2551     ISO Abbreviation:  Rev Port Cardiol     Publication Date:  1998 Dec 
Date Detail:
Created Date:  1999-03-05     Completed Date:  1999-03-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8710716     Medline TA:  Rev Port Cardiol     Country:  PORTUGAL    
Other Details:
Languages:  eng     Pagination:  981-91     Citation Subset:  IM    
Affiliation:
Department of Cardiology and Angiology, Institute of Arteriosclerosis Research, Westfalian Wilhems-University of Münster, Germany. breithg@uni-muenster.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use*
Clinical Trials as Topic
Death, Sudden, Cardiac / prevention & control
Defibrillators, Implantable
Humans
Philosophy, Medical*
Prognosis
Tachycardia, Ventricular / drug therapy*
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The surgical treatment of acute myocardial infarct in the 90s
Next Document:  Antiplatelet drugs in secondary prevention after acute myocardial infarction.